查看完整行情页>>
|
货币单位:美元(USD)
Aeglea Biotherapeutics, Inc. (agle)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 交易日期 |
交易人 |
职位 |
类型 |
交易份额 |
价格 |
| 2017-02-20 |
Orbimed Advisors, L.L.C. |
Beneficial Owner of More than 10% Class |
Buy |
7000 |
5.36 |
| 2017-02-16 |
Orbimed Advisors, L.L.C. |
Beneficial Owner of More than 10% Class |
Buy |
71800 |
5.19 |
| 2017-02-15 |
Orbimed Advisors, L.L.C. |
Beneficial Owner of More than 10% Class |
Buy |
30500 |
5.04 |
| 2016-04-11 |
York (Charles N. ii CPA) |
Chief Financial Officer |
Buy |
11560 |
-- |
| 2016-04-11 |
Tyler Joseph E |
Officer |
Buy |
31260 |
-- |
| 2016-04-11 |
Rowlinson (Scott W) |
Officer |
Buy |
11204 |
-- |
| 2016-04-11 |
Quinn (Anthony G) |
Director |
Buy |
10000 |
10.00 |
| 2016-04-11 |
Cox (Russell J) |
Director |
Buy |
7000 |
10.00 |
| 2016-04-11 |
Novartis Bioventures, Ltd. |
Beneficial Owner of More than 10% Class |
Buy |
300000 |
10.00 |
| 2016-04-11 |
Novartis Bioventures, Ltd. |
Beneficial Owner of More than 10% Class |
Buy |
2010924 |
-- |
| 2016-04-11 |
Lowe (David G) |
Chief Executive Officer |
Buy |
5658 |
-- |
| 2016-04-11 |
Lilly Eli & Co |
Beneficial Owner of More than 10% Class |
Buy |
2010924 |
-- |
| 2016-04-11 |
Lilly Eli & Co |
Beneficial Owner of More than 10% Class |
Buy |
500000 |
10.00 |
| 2016-04-11 |
York (Charles N. ii CPA) |
Chief Financial Officer |
Buy |
1324 |
-- |
| 第 页, 共 1 页 首页 上页 下页 末页 |
